TRV GP VI’s Seaport Therapeutics SPTX Stock Holding History

TRV GP VI’s Portfolio SPTX Stock Details SPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.8M	Buy	+2,061,222	New	+$36.3M	19.27%	2

Other funds holding SPTX

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TRV GP VI's SPTX Position: Q2 2026 in Review

TRV GP VI opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 2,061,222 shares worth $44.8M. The stake represents 19.27% of the portfolio and ranks #2 among its holdings.

47 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

TRV GP VI held 2,061,222 shares of Seaport Therapeutics worth $44.8M as of Q2 2026.
Seaport Therapeutics was a new TRV GP VI position in Q2 2026.
Seaport Therapeutics made up 19.27% of TRV GP VI's portfolio in Q2 2026, its #2 holding.
47 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on TRV GP VI's 13F filing for Q2 2026, filed 10 Aug 2026.